Biora Therapeutics, Inc. (BIORQ) Stock Overview
Explore Biora Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Biora Therapeutics, Inc. (BIORQ)
Key Financials
Key Financials
Market Cap
905
P/E Ratio
-0.00
EPS (TTM)
$-16.30
ROE
1.22%
BIORQ Stock Analysis & Investment Overview (PNK)
Our AI-powered analysis of Biora Therapeutics, Inc. (PNK: BIORQ) gives investors deep insight into how the stock performs on the PNK exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Biora Therapeutics, Inc.'s PNK-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BIORQ on the PNK shows an RSI of 49.51, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the PNK listing.
Key metrics behind Biora Therapeutics, Inc.'s PNK-traded stock include a P/E ratio of -0.00 and a market capitalization of 905. Combined with our AI analysis, these give both institutional and retail investors a clear view of BIORQ on the PNK.